Vivek Kashyap to Antitubercular Agents
This is a "connection" page, showing publications Vivek Kashyap has written about Antitubercular Agents.
Connection Strength
0.334
-
Chouhan M, Kumar M, Dwivedi VD, Kashyap VK, Singh HN, Kumar S. Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy. Adv Respir Med. 2025 Jun 16; 93(3).
Score: 0.225
-
Singh S, Roy KK, Khan SR, Kashyap VK, Sharma A, Jaiswal S, Sharma SK, Krishnan MY, Chaturvedi V, Lal J, Sinha S, Dasgupta A, Gupta AD, Srivastava R, Saxena AK. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Bioorg Med Chem. 2015 Feb 15; 23(4):742-52.
Score: 0.109